Abstract

BackgroundSynthetic virology is an important multidisciplinary scientific field, with emerging applications in biotechnology and medicine, aiming at developing methods to generate and engineer synthetic viruses. In particular, many of the RNA viruses, including among others the Dengue and Zika, are widespread pathogens of significant importance to human health. The ability to design and synthesize such viruses may contribute to exploring novel approaches for developing vaccines and virus based therapies.ResultsHere we develop a full multidisciplinary pipeline for generation and analysis of synthetic RNA viruses and specifically apply it to Dengue virus serotype 2 (DENV-2). The major steps of the pipeline include comparative genomics of endogenous and synthetic viral strains. Specifically, we show that although the synthetic DENV-2 viruses were found to have lower nucleotide variability, their phenotype, as reflected in the study of the AG129 mouse model morbidity, RNA levels, and neutralization antibodies, is similar or even more pathogenic in comparison to the wildtype master strain. Additionally, the highly variable positions, identified in the analyzed DENV-2 population, were found to overlap with less conserved homologous positions in Zika virus and other Dengue serotypes. These results may suggest that synthetic DENV-2 could enhance virulence if the correct sequence is selected.ConclusionsThe approach reported in this study can be used to generate and analyze synthetic RNA viruses both on genotypic and on phenotypic level. It could be applied for understanding the functionality and the fitness effects of any set of mutations in viral RNA and for editing RNA viruses for various target applications.

Highlights

  • Synthetic virology is an important multidisciplinary scientific field, with emerging applications in biotechnology and medicine, aiming at developing methods to generate and engineer synthetic viruses

  • In this work we demonstrate, for the first time, a comprehensive analysis of Dengue virus serotype 2 (DENV-2) (Dengue virus, serotype 2) synthetic variants using a multidisciplinary pipeline that combines comparative genomics, synthetic biology, generation sequencing, and experiments with animal models of viral infection

  • Study outline The full comparative genomics pipeline for synthetic biology of RNA viruses demonstrated in this study is described in Fig. 1: DENV2 New Guinea C wild type viral strain (Fig. 1 I) was sequenced (Sanger; Fig. 1 II; see Additional file 1, section 8)

Read more

Summary

Introduction

Synthetic virology is an important multidisciplinary scientific field, with emerging applications in biotechnology and medicine, aiming at developing methods to generate and engineer synthetic viruses. Many of the RNA viruses, including among others the Dengue and Zika, are widespread pathogens of significant importance to human health. The ability to synthesize and engineer RNA viruses has important applications to biotechnology and human health [1,2,3,4,5]. Since dengue is an important human pathogen, widely recognized as a major public health concern [18], new insights into its biological and evolutionary properties including its wildtype and synthetically generated strains may have significant influence on the development of new antiviral. The Zika virus (ZIKV), of the flavivirus genus, is closely related to DENV and was recently classified as a public health emergency of international concern due to recent outbreaks [19, 20]. The DENV and ZIKV genomes encode three structural proteins (capsid, precursor membrane, and envelope) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [21, 22]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call